Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain XENT message board posts where the ticker symbol XENT has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest XENT SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-17-003867 Size: 9 KB
2017-12-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-17-003742 Size: 9 KB
2017-12-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-17-003642 Size: 8 KB
2017-11-20
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-17-003629 Size: 10 KB
2017-11-17
SC 13G  Documents Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001193805-17-003503 (34 Act)  Size: 119 KB
2017-11-16 005-88513
171207729
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-17-003559 Size: 4 KB
2017-11-14
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-17-003492 Size: 9 KB
2017-11-06
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001193125-17-334283 (34 Act)  Size: 2 MB
2017-11-06 001-36545
171179635
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001193125-17-331075 (34 Act)  Size: 68 KB
2017-11-02 001-36545
171172790
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-17-003271 Size: 10 KB
2017-10-17
More XENT SEC Filings


Related news from
Wed, 13 Dec 2017
13:46:01 +0000
Intersect ENT (XENT) SINUVA Implant Receives FDA Approval
Intersect ENT's (XENT) consistent focus on the chronic sinusitis market is likely to lend the company a competitive edge in the niche space.
Mon, 11 Dec 2017
13:00:00 +0000
Intersect ENT Announces FDA Approval of SINUVA™ Sinus Implant, a New In-Office Treatment Option for Recurrent Nasal Polyps
Intersect ENT, Inc. , a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that it has received approval from the U.S.
Thu, 07 Dec 2017
21:05:00 +0000
Intersect ENT to Present at the 36th Annual J.P. Morgan Healthcare Conference
Intersect ENT, Inc. , today announced that management will present an overview of the company's business at the 36th Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018 at 2:30 p.m.
Wed, 06 Dec 2017
12:44:50 +0000
Intersect ENT, Inc. breached its 50 day moving average in a Bearish Manner : XENT-US : December 6, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intersect ENT, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more <b>(Read more...)</b>
Fri, 24 Nov 2017
16:41:00 +0000
Intersect ENT, Inc. – Value Analysis (NASDAQ:XENT) : November 24, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Intersect ENT, Inc. a score of 61. Our analysis is based on comparing Intersect ENT, Inc. with the following peers – Ocular Therapeutix Inc, KalVista Pharmaceuticals, Inc., Aradigm Corporation and Anika Therapeutics, Inc. (OCUL-US, KALV-US, ARDM-US and ANIK-US). Investment Outlook Intersect ENT, Inc. has a fundamental score ... Read more <b>(Read more...)</b>
Thu, 23 Nov 2017
12:16:06 +0000
Intersect ENT, Inc. breached its 50 day moving average in a Bullish Manner : XENT-US : November 23, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intersect ENT, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more <b>(Read more...)</b>
Tue, 07 Nov 2017
13:41:09 +0000
Edited Transcript of XENT earnings conference call or presentation 2-Nov-17 8:30pm GMT
Q3 2017 Intersect ENT Inc Earnings Call
Thu, 02 Nov 2017
21:45:30 +0000
Intersect ENT reports 3Q loss
On a per-share basis, the Menlo Park, California-based company said it had a loss of 15 cents. The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment ...
Mon, 23 Oct 2017
12:09:58 +0000
Intersect ENT, Inc. breached its 50 day moving average in a Bullish Manner : XENT-US : October 23, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intersect ENT, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more <b>(Read more...)</b>
Mon, 16 Oct 2017
20:05:00 +0000
Intersect ENT to Report Third Quarter 2017 Financial Results
Intersect ENT, Inc. , a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for its third quarter on November 2, 2017.
Wed, 11 Oct 2017
12:32:12 +0000
The Zacks Analyst Blog Highlights: IDEXX Laboratories, Steris, K2M Group Holdings, Tandem Diabetes Care and Intersect ENT
The Zacks Analyst Blog Highlights: IDEXX Laboratories, Steris, K2M Group Holdings, Tandem Diabetes Care and Intersect ENT
Tue, 10 Oct 2017
20:59:08 +0000
5 MedTech Stocks for Stellar Returns in Q3
Here we take a sneak peek into two burning issues that are likely to impact the quarterly numbers in the MedTech fraternity.
Tue, 10 Oct 2017
15:56:13 +0000
ETFs with exposure to Intersect ENT, Inc. : October 10, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Intersect ENT, Inc. Here are 5 ETFs with the largest exposure to XENT-US. Comparing the performance and risk of Intersect ENT, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more <b>(Read more...)</b>
Mon, 09 Oct 2017
13:52:57 +0000
Intersect ENT, Inc. :XENT-US: Earnings Analysis: Q2, 2017 By the Numbers : October 9, 2017
Categories: Yahoo FinanceGet free summary analysis Intersect ENT, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 23.99 million, Net Earnings of USD -2.27 million. Gross margins widened from 83.86% to 84.64% compared to the same period last year, operating (EBITDA) margins now -9.16% from -30.56%. Change in operating ... Read more <b>(Read more...)</b>
Sun, 08 Oct 2017
15:00:00 +0000
Intersect ENT Announces Presentation of Results from RESOLVE II, a Pivotal Phase III Study Evaluating the Safety and Efficacy of SINUVA™, an Investigational Steroid Releasing Sinus Implant
Intersect ENT, Inc. , a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced the first presentation of results from RESOLVE II, a randomized, double-blinded, controlled Phase III clinical trial, which assessed the safety and efficacy of SINUVA™, an investigational steroid releasing sinus implant.
Thu, 05 Oct 2017
20:47:08 +0000
The Saga to Revoke Obamacare Continues: 3 MedTech Picks
In the wake of the turbulent political scenario and banking on favorable metrics, these three MedTech stocks stand out as the most suitable picks.
Fri, 22 Sep 2017
15:47:34 +0000
Intersect ENT, Inc. – Value Analysis (NASDAQ:XENT) : September 22, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Intersect ENT, Inc. a score of 61. Our analysis is based on comparing Intersect ENT, Inc. with the following peers – Ocular Therapeutix Inc, KalVista Pharmaceuticals, Inc., Aradigm Corporation and Anika Therapeutics, Inc. (OCUL-US, KALV-US, ARDM-US and ANIK-US). Investment Outlook Intersect ENT, Inc. has a fundamental score ... Read more <b>(Read more...)</b>
Thu, 21 Sep 2017
14:19:07 +0000
Intersect ENT, Inc. breached its 50 day moving average in a Bearish Manner : XENT-US : September 21, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intersect ENT, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more <b>(Read more...)</b>
Sat, 09 Sep 2017
20:30:00 +0000
Intersect ENT Announces Presentation of a Meta-Analysis From Two Randomized Studies Evaluating the Safety and Efficacy of SINUVA™, an Investigational Steroid Releasing Sinus Implant
Intersect ENT, Inc. , a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced presentation of a meta-analysis from two randomized studies evaluating the safety and efficacy of SINUVA™, an investigational steroid releasing sinus implant.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF is an awesome community of bright, serious, passionate and involved individual investors. Information is well organized into fine-grained topics and discussions are always on topic and relevant. People here certainly know what value is and this site itself is a great reflection of that. I feel honored and privileged to have found such a great resource and to be part of it!" more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2017, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards